Funding Information: The work was funded by internal grants (MSI and Cancer Challenge 2022) provided by the Institute for Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and by national funds through FCT in the scope of the project 2022.05346.PTDC (https://doi.org/10.54499/2022.05346.PTDC). This article is also a result of the projects (iNOVA4Health\u2013UIDB/04462/2020 and UIDP/04462/2...